Radium-223 Chloride: A New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma

ISSN： 1174-5886

Source： Drugs in R&D, Vol.12, Iss.4, 2012-12, pp. : 227-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New agents and strategies for the hormonal treatment of castration-resistant prostate cancer

By Sharifi Nima

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 837-846

Informa Healthcare

Access to resources Recommend Favorite

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Abiraterone Acetate: In Metastatic Castration-Resistant Prostate Cancer

By Yang Lily P.H.

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2067-2077

Adis International

Access to resources Recommend Favorite

A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration‐Resistant Prostate Cancer

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 5, 2015-05 ,pp. : 277-285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radium-223 for the treatment of prostate cancer

By Hafeez Shaista Parker Christopher

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 379-387

Informa Healthcare

Access to resources Recommend Favorite